Press Release Summary:
Suited for use by medical professionals, hospitals, and managed care facilities, PulseOx 6000(TM) and PulseOx 6100(TM) are finger and hand held devices, respectively, that use Reflective Pulse Oximetry technology for measurements of blood oxygen saturation and heart rate. Units include AutoSpot(TM) technology for patients suffering low perfusion.
Original Press Release:
SPO Medical Unveils New Oximetry Devices in the US Market
Products to be launched at AARC International Respiratory Congress in Orlando, Florida
NEW YORK, Nov. 29 /-- SPO Medical Inc. (BULLETIN BOARD: SPOM) , a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, will be demonstrating its new PulseOx 6000(TM) and PulseOx 6100(TM) in the US market at the 53rd Annual International Respiratory Congress of the American Association for Respiratory Care (AARC) in Orlando, Florida (December 1-3, 2007).
The PulseOx 6000(TM) (finger device) and PulseOx 6100(TM) (hand-held device) have both been designed for use by medical professionals, hospitals and managed care facilities. Both the PulseOx 6000(TM) and PulseOx 6100(TM) use patented Reflective Pulse Oximetry (RPO) technology for accurate and reliable measurements of blood oxygen saturation and heart rate, and include the SPO Medical new AutoSpot(TM) technology for patients suffering low perfusion. Both products have regulatory clearance for marketing in the United States and are planned to become commercially available in the first quarter of 2008.
"We are delighted to introduce the PulseOx 6000(TM) and PulseOx 6100(TM) for the first time in the US at AARC's International Respiratory Congress, the most prestigious gathering of respiratory care professionals," said Michael Braunold, President and Chief Executive Officer of SPO Medical. "Our business strategy and product achievements to date are a testament to our continued success in delivering new life-saving and life-enhancing products to the respiratory marketplace."
AARC, a professional membership association of respiratory therapists, focuses primarily on respiratory therapy education and research. Its goals are to ensure that respiratory patients receive safe and effective care from qualified professionals and to benefit respiratory health care providers. AARC's International Respiratory Congress is a one-stop destination for the latest scientific evidence on the care and treatment of respiratory conditions and the newest and most advanced respiratory technology.
SPO Medical will be located at booth #237 and their executives will be available to answer questions at the AARC International Respiratory Congress.
About SPO Medical:
SPO Medical (SPOM) a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices to capture life-saving and life-enhancing information within four key markets: medical care; home and remote-care; sports and wellness; and safety and security. Its patented technology uses information gathered from the reflectance of light on the human blood stream, in a non-invasive manner, to monitor key vital signs. The Company distributes its products through a network of distributors and also licenses its technologies to appropriate client corporations for commercialization and distribution. For more information, visit www.spomedical.com.
CONTACT: Michael Braunold, CEO of SPO Medical Inc., 011-972-9-7643570, email@example.com
Web site: www.spomedical.com/